Targeted killing effects of double CD and TK suicide genes controlled by survivin promoter on gastric cancer cell (Q39688817)

14 September 2017

title

Targeted killing effects of double CD and TK suicide genes controlled by survivin promoter on gastric cancer cell (English)

1 reference

14 September 2017

0 references

Xian-Run Luo

1

1 reference

14 September 2017

Jian-Sheng Li

series ordinal

2

1 reference

14 September 2017

Ying Niu

series ordinal

3

1 reference

14 September 2017

Li Miao

series ordinal

4

1 reference

14 September 2017

language of work or name

1 reference

24 June 2010

1 reference

Molecular Biology Reports

14 September 2017

published in

1 reference

14 September 2017

volume

38

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

1201-1207

1 reference

Current management of gastric cancer

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Adenocarcinoma of the stomach: are we making progress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Multidisciplinary approach to understand the pathogenesis of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil, and calcium folinate in patients with gastric cancer: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Recombinant human interleukin-24 suppresses gastric carcinoma cell growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

GENE THERAPY FOR THE TREATMENT OF PITUITARY TUMORS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Adenoviral vector-based strategies for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

A novel Bifidobacterium infantis-mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Combined suicide and cytokine gene therapy for peritoneal carcinomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Selective suicide gene therapy of colon cancer exploiting the urokinase plasminogen activator receptor promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Validating survivin as a cancer therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Targeted therapy by disabling crossroad signaling networks: the survivin paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Induced epigenetic modifications of the promoter chromatin silence survivin and inhibit tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Improved nonviral cancer suicide gene therapy using survivin promoter-driven mutant Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Correlation between the levels of survivin and survivin promoter-driven gene expression in cancer and non-cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Detection of cytosine deaminase in genetically modified tumor cells by specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Designing a HER2/neu promoter to drive alpha1,3galactosyltransferase expression for targeted anti-alphaGal antibody-mediated tumor cell killing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Transcriptional targeting of tumors with a novel tumor-specific survivin promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Targeted therapy for malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression

21 January 2018

1 reference

12 December 2020

In vitro model of suicide gene therapy for alpha-fetoprotein-producing gastric cancer

1 reference

12 December 2020

Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation

1 reference

12 December 2020

Horseradish peroxidase-mediated gene therapy: choice of prodrugs in oxic and anoxic tumor conditions.

1 reference

12 December 2020

Specific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene.

1 reference

12 December 2020

Cimetidine induces apoptosis in gastric cancer cells in vitro and inhibits tumor growth in vivo.

1 reference

12 December 2020

Induction chemotherapy with docetaxel, 5-FU and CDDP (DFP) for advanced gastric cancer.

1 reference

12 December 2020

Targeted antitumor effect induced by hTERT promoter mediated ODC antisense adenovirus

1 reference

12 December 2020

Cancer-specific gene therapy.

1 reference

12 December 2020

Gastric adenocarcinoma: review and considerations for future directions

1 reference

12 December 2020

Recent progress in gene-directed enzyme prodrug therapy: an emerging cancer treatment

1 reference

12 December 2020

Combination gene therapy of lung cancer with conditionally replicating adenovirus and adenovirus-herpes simplex virus thymidine kinase.

1 reference

12 December 2020

10.1007/S11033-010-0218-8

Identifiers

DOI

1 reference

14 September 2017

1 reference